Cameron A. Gee

Cameron A. Gee, Vedder Price Law Firm, Finance Attorney
Cameron A. Gee
Shareholder
Vedder Price
Website
www.vedderprice.com
Organization Profile
Full Profile
Connect
Email
212-407-6929
Professional Biography

Cameron A. Gee is a shareholder at Vedder Price. As a member of the Equipment Finance Group, he serves on the Commercial Aviation, Equipment Finance, ABS/Securitization, Project Finance and Infrastructure, and Rail subgroups.

  • More Legal and Business Bylines From Cameron A. Gee

Current Legal Analysis

The First 100 Days: President Trump’s Federal Policy Revamp and New Compliance Concerns for Employers
by: Zachary V. Zagger
China Releases Regulations on the Protection of New Plant Varieties
by: Aaron Wininger
Beltway Buzz, May 2, 2025
by: James J. Plunkett
2026 Inflation-Adjusted Health and Welfare Plan Limits
by: Michelle (Mickey) Bartlett , Brian T. Gallagher
The Courts Weigh in on OCR’s Title VI Guidance and the U.S. Department of Education’s Certification Requirements
by: Amy Fabiano , Brigid Harrington
Understanding Community Association Authority: Regulating Parking on Community Streets in North Carolina
by: Hunter D. Cornelius , Madeline C. Lipe
Lamar Jackson Successfully Opposes Dale Earnhardt Jr.’s Claim to No. 8
by: Benjamin D. Schwartz
Medicare Drug Price Negotiation Program: The Inflation Reduction Act “Pill Penalty” and Other IRA Reforms on the Horizon for 2026
by: Constance A. Wilkinson , Alan J. Arville
DoD AI Compliance Guidance for Government Contractors
by: Robert A. Broadbent
Similar Language But a Different Outcome: Medicare DSH Payments after Advocate Christ Medical Center v. Kennedy
by: Robert E. Wanerman
April NEPA Roundup
by: Joe Beletti-Naccarato
OCR Reaches Settlement with Health Care Network Health Over HIPAA Violations Stemming from Phishing Attack
by: Hunton Andrews Kurth’s Privacy and Cybersecurity
New Jersey Employers: Pay Transparency Arrives June 1
by: Jill Turner Lever , Vimal K. Shah
Final Opportunity to Shape SFDR’s Future in European Commission’s Call for Evidence
by: Rachel E. Lowe , John Verwey
Constitutional Reform Initiative Regarding Pharmaceutical Sovereignty and Safety
by: Gustavo A. Alcocer , Alejandro Luna Fandiño

Upcoming Events

 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters